A newly published study from researchers at Ohio State University has found the recently emerged BA.2.86 variant of SARS-CoV-2 has a greater propensity for infecting certain lung cells than any prior ...

Molecular biology tech, Sarah Corcoran, prepares SARS-CoV-2 samples as part of the RNA sequencing process at Ohio State University, US. [Reuters] The following is a summary of some recent studies on ...

In a recent study published in the Proceedings of the National Academy of Sciences, researchers explored the shortcomings in mucosal immunoglobulin A (IgA) responses induced by existing vaccines ...

A recent study by Ohio State researchers shows that a new omicron subvariant of COVID-19 can be neutralized by the dual-strain vaccine, preventing the worldwide escalation of cases that was initially ...

JOHANNESBURG - The omicron variant appears to cause less severe disease than previous versions of the coronavirus, and the Pfizer vaccine seems to offer less defense against infection from it but ...

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains ...

An electron microscope image of the coronavirus that causes COVID-19. (Photo courtesy of NIAID-RML) The risk of reinfection with the omicron coronavirus variant is more than five times higher and it ...

In a recent study in Nature Microbiology, researchers compared severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC) replication in human cell lines and primary ...

The omicron COVID-19 variant that swept the world in late 2021 and early 2022 is not as likely to cause long COVID in those who get infected, a study released Thursday determined. The study was ...

The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations by picking up a snippet of genetic material from another virus - possibly one that causes the common ...

• C-reactive protein (CRP) >41.8 mg/L, interstitial lung disease (ILD) as primary disease, and combined pulmonary fungal infection are high-risk factors for developing severe disease in lung ...